Related Experiment Video
Updated: Jun 27, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
PTPN22 allele polymorphisms in 15 Chinese populations
1Laboratory of Medical Genetics, Harbin Medical University, Harbin, China.
International Journal of Immunogenetics
|December 3, 2008
Summary
The PTPN22 gene
Area of Science:
- Immunogenetics
- Molecular Biology
- Population Genetics
Background:
- Protein tyrosine phosphatase non-receptor 22 (PTPN22) plays a crucial role in regulating T-cell responses.
- A specific single nucleotide polymorphism (SNP), C1858T, in the PTPN22 gene, leads to an Arg620Trp substitution in lymphoid protein tyrosine phosphatase (LYP).
- This PTPN22 polymorphism is linked to an elevated risk of developing various autoimmune diseases.
Purpose of the Study:
- To investigate the frequency and distribution of the PTPN22-C1858T polymorphism in diverse Chinese populations.
- To determine the allelic and genotypic frequencies of this SNP across northern and southern China.
Main Methods:
- Genotyping of 1085 individuals from 15 distinct Chinese populations using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
- Digestion of amplified DNA fragments with the restriction endonuclease RsaI to identify genotypes.
- Statistical analysis to assess the variance in allele frequencies across populations.
Main Results:
- The PTPN22-1858T allele frequency was found to be 1.43% among the 1085 individuals studied.
- Thirty-one individuals were identified as heterozygotes (PTPN22-1858C/T).
- A statistically significant variation (chi(2) = 74.1650, P < 0.01) in the frequencies of the PTPN22-1858T allele was observed across the 15 Chinese populations.
Conclusions:
- The PTPN22-C1858T polymorphism exhibits significant population-specific frequency variations within China.
- These findings contribute to understanding the genetic landscape of autoimmune disease risk factors in Asian populations.
- Further research is warranted to explore the functional implications of these observed frequency differences.
More Related Videos
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...